CBX3 and colorectal carcinoma: Since CBX3 KO can render IFNγ-insensitive CRC cells becoming dramatically sensitive to IFNγ stimulation, we further investigated whether this restored sensitivity to IFNγ could make CBX3 KO CRC cells more sensitive to chemotherapy.